AzTrials
AzTrials

ElastographyCKD-SWENCT04404114

Shear Wave Elastography in Differentiating Acute or Chronic Kidney Disease

An observational study of Elastography and Chronic Kidney Diseases, run by National Taiwan University Hospital at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Chronic kidney disease is a common global public health issue and its prevalence increased year by year. Early diagnosis and intervention can prevent further complications and comorbidities of long-term dialysis, cardiovascular events and mortality as well as improve the patients' life quality. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Elastography, Chronic Kidney Diseases
What is being tested?
Shear wave elastography to distinguish AKI from normal kidney, Shear wave elastography to distinguish AKI from CKD and Shear wave elastography to distinguish CKD from normal kidney
How many people
800 participants
Where
1 siteTaiwan
Study dates
1 Feb 2020to 31 Dec 2026
How long will I take part?
2 Weeks
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Approximately 400 patients with normal kidney function and 400 patients with abnormal kidney function

Who may be able to join

  • The patients older than 20 years old who needed to receive renal sonography in emergency department of National Taiwan University Hospital.

Who cannot join

  • The patients who didn't obtain agreement.
  • The patients who can't cooperate or follow the directions

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wan C. Lien, A.P contact

+886 972651315

dtemer17@yahoo.com.tw

Jia Yu Chen, Resident contact

+886 972652447

qwe96963@gmail.com

Taiwan1 site, 1 recruiting
  • National Taiwan University Hospital

    Taipei, 100

    Wan-Ching Lien, MD., PhD, +886-2-23123456 ext. 65637, wanchinglien@ntu.edu.tw

    Jia-Yu Chen, MD., qwe96963@gmail.com

    Recruiting

Other trials in Taiwan

About this study

Chronic kidney disease is a common global public health issue and its prevalence increased year by year. Early diagnosis and intervention can prevent further complications and comorbidities of long-term dialysis, cardiovascular events and mortality as well as improve the patients' life quality. To differentiate acute from chronic kidney disease was crucial especially in the setting of crowded and high-risk emergency department. To diagnose acute or chronic kidney disease, physicians usually use blood sample test combined with image studies such as conventional sonography, CT and MRI. However, there was lots of limited factors. The patients may have no previous visit records, poor renal function to receive contrast medium, or critical clinical condition to undergo time-wasting exam. Although the conventional renal sonography is accessible and inexpensive, the judgement is subjective and provide little clinical information. Recent researches of shear wave elastography in evaluating renal parenchymal stiffness showed some correlation with nephropathy. In our study, aiming to facilitating clinical implication, the investigators will use swear-wave elastography combined with conventional renal sonography to benefit patients in diagnosis of acute or chronic kidney disease.

Read the detailed description

This is a case-control study. The investigators obtained data from participants who were older than 20 years old and received renal sonography examination in the emergency department of National Taiwan University Hospital. The investigators examined the participants' kidneys by recording the kidney size, cortical thickness, possible lesions and elasticity by shear-wave elastography. These data combined with the participants' medical history and renal function revealed by blood examination will be analyzed. This study was designed to determine the correlation between renal cortical elasticity and chronic kidney disease.

Being tested
Shear wave elastography to distinguish AKI from normal kidney, Shear wave elastography to distinguish AKI from CKD, Shear wave elastography to distinguish CKD from normal kidney
Medical subject headings
Renal Insufficiency, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Shear wave elastography to distinguish AKI from normal kidneyDiagnostic test

    Record the patient's kidney size, cortical thickness, possible lesion by ordinary renal sonography as well as cortical elasticity by shear wave elastography

  • Shear wave elastography to distinguish AKI from CKDDiagnostic test

    Record the patient's kidney size, cortical thickness, possible lesion by ordinary renal sonography as well as cortical elasticity by shear wave elastography

  • Shear wave elastography to distinguish CKD from normal kidneyDiagnostic test

    Record the patient's kidney size, cortical thickness, possible lesion by ordinary renal sonography as well as cortical elasticity by shear wave elastography

Study groups in NCT04404114
Study groupRoleWhat they receive
Normal renal functionNormal renal function
Receives: Diagnostic Test: Shear wave elastography to distinguish AKI from normal kidney
Acute kidney injury in normal kidneyAcute kidney injury in normal kidney
Receives: Diagnostic Test: Shear wave elastography to distinguish AKI from normal kidney
Acute kidney injury in chronic kidney diseaseAcute kidney injury in chronic kidney disease
Receives: Diagnostic Test: Shear wave elastography to distinguish AKI from CKD
Chronic kidney diseaseChronic kidney disease
Receives: Diagnostic Test: Shear wave elastography to distinguish CKD from normal kidney

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To determine the correlation of kPa ratio and renal function in chronic renal disease

    The analysis will be conducted to determine the correlation between kPa ratio measured by elastography and renal function in patients with chronic renal disease

    Measured: change in renal function after 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2020
  2. Study start1 Feb 2020
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
800 participants (estimated)
Target duration
2 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT04404114
Sponsor's protocol ID
202001091RINC
Acronym
CKD-SWE
Status last verified
Oct 2025
First submitted
28 Apr 2020
Last updated
18 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Elastography and Chronic Kidney Diseases, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wan C. Lien, A.P (+886 972651315, dtemer17@yahoo.com.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To determine the correlation of kPa ratio and renal function in chronic renal disease (time frame: change in renal function after 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in